Squarepoint Ops LLC Esperion Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 210,222 shares of ESPR stock, worth $491,919. This represents 0.0% of its overall portfolio holdings.

Number of Shares

210,222

Holding current value

$491,919

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.61 - $2.73 $338,457 - $573,906	210,222 New	210,222 $346,000
Q1 2024 May 15, 2024	BUY	$2.02 - $3.02 $429,427 - $642,015	212,588 Added 242.37%	300,300 $804,000
Q4 2023 Feb 14, 2024	BUY	$0.73 - $3.08 $64,029 - $270,152	87,712 New	87,712 $262,000
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $77,971 - $389,856	53,405 Added 40.6%	184,941 $294,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $375,000 - $626,229	73,674 Added 127.33%	131,536 $819,000
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $53,393 - $79,649	9,797 Added 20.38%	57,862 $388,000
Q2 2022 Aug 15, 2022	BUY	$4.77 - $6.67 $229,270 - $320,593	48,065 New	48,065 $306,000
Q1 2022 May 16, 2022	SELL	$3.34 - $5.56 $241,655 - $402,277	-72,352 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $707 - $1,752	-147 Reduced 0.2%	72,352 $362,000
Q3 2021 Nov 15, 2021	BUY	$11.34 - $21.37 $377,202 - $710,830	33,263 Added 84.78%	72,499 $874,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $382,005 - $565,328	19,691 Added 100.75%	39,236 $830,000
Q1 2021 May 17, 2021	BUY	$25.12 - $36.89 $111,432 - $163,644	4,436 Added 29.36%	19,545 $548,000
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $365,637 - $540,297	15,109 New	15,109 $393,000
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $754,051 - $2.03 Million	-27,480 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$35.4 - $59.82 $71,224 - $120,357	-2,012 Reduced 6.82%	27,480 $1.64 Million
Q3 2019 Nov 14, 2019	BUY	$34.47 - $47.53 $313,401 - $432,142	9,092 Added 44.57%	29,492 $1.08 Million
Q2 2019 Aug 14, 2019	SELL	$40.1 - $52.33 $627,284 - $818,598	-15,643 Reduced 43.4%	20,400 $949,000
Q1 2019 May 15, 2019	BUY	$40.11 - $53.57 $756,514 - $1.01 Million	18,861 Added 109.77%	36,043 $1.45 Million
Q4 2018 Feb 14, 2019	SELL	$36.99 - $59.11 $430,045 - $687,212	-11,626 Reduced 40.36%	17,182 $790,000
Q3 2018 Nov 14, 2018	SELL	$40.74 - $51.41 $567,915 - $716,655	-13,940 Reduced 32.61%	28,808 $1.28 Million
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $863,804 - $1.82 Million	23,862 Added 126.35%	42,748 $1.68 Million
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $564,512 - $691,386	8,561 Added 82.92%	18,886 $1.37 Million
Q4 2017 Feb 14, 2018	BUY	$43.47 - $67.43 $448,827 - $696,214	10,325	10,325 $680,000

Others Institutions Holding ESPR

# of Institutions

206

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $156M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Esperion Therapeutics, Inc. Transaction History